Back
Tricia Carrigan
Advisor
Experience
Global Precision Medicine team builder with an emphasis on transforming concepts into personalized diagnostic products. Advanced development, regulatory approval, and commercialization of biomarker in vitro diagnostic assays and Artificial Intelligence Software Algorithms (SaMD) in Oncology, Neuroscience, Cardiovascular, and Women’s Health.
Previous Companies
Merck (AVP, Companion Diagnostic Oncology), Bayer (Global Regulatory Head- Companion Diagnostics, Oncology, Women’s Health, and Cardiovascular), and Roche Ventana.